Seddon Johanna M, McLeod D Scott, Bhutto Imran A, Villalonga Mercedes B, Silver Rachel E, Wenick Adam S, Edwards Malia M, Lutty Gerard A
Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Boston, Massachusetts2Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts3Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts.
Department of Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, Maryland.
JAMA Ophthalmol. 2016 Nov 1;134(11):1272-1280. doi: 10.1001/jamaophthalmol.2016.3519.
Age-related macular degeneration (AMD) is a multifactorial disease with genetic and environmental factors contributing to risk. Histopathologic changes underlying AMD are not fully understood, particularly the relationship between choriocapillaris (CC) dysfunction and phenotypic variability of this disease.
To examine histopathologic changes in the CC of eyes with clinically documented AMD.
DESIGN, SETTING, AND PARTICIPANTS: The study was designed in 2011. Tissues were collected post mortem (2012-2016), and histopathological images were obtained from participants enrolled in AMD studies since 1988. Clinical records and images were collected from participants as standard protocol. Eyes without AMD (n = 4) and eyes with early (n = 9), intermediate (n = 5), and advanced stages of AMD (geographic atrophy, n = 5; neovascular disease, n = 13) were evaluated. Choroidal vasculature was labeled using Ulex europaeus agglutinin lectin and examined using confocal microscopy.
A standardized classification system was applied to determine AMD stage. Ocular records and images were reviewed and histopathologic analyses performed. Viability of the choroidal vasculature was analyzed for each AMD stage.
All participants were white. Fourteen were male, and 16 were female. The mean age was 90.5 years among AMD patients and 88.5 years among control participants. Submacular CC dropout without retinal pigment eipthelial (RPE) loss was observed in all cases with early stages of AMD. Higher vascular area loss for each AMD stage was observed compared with control participants: 20.5% in early AMD (95% CI, 11.2%-40.2%; P < .001), 12.5% in intermediate AMD (95% CI, 2.9%-21.4%; P = .01), 39.0% loss in GA (95% CI, 32.1%-45.4%; P < .001), and 38.2% loss in neovascular disease where RPE remained intact (95% CI, 27.7%-47.9%; P < .001). Hypercellular, apparent neovascular buds were adjacent to areas of CC loss in 22.2% of eyes with early AMD and 40% of eyes with intermediate AMD.
Retinal pigment epithelial atrophy preceded CC loss in geographic atrophy, but CC loss occurred in the absence of RPE atrophy in 2 of 9 eyes with early-stage AMD. Given the cross-sectional nature of this study and the small number of eyes evaluated, definitive conclusions regarding this progression cannot be determined with certainty. We speculate that neovascular buds may be a precursor to neovascular disease. Hypoxic RPE resulting from reduced blood supply might upregulate production of vascular endothelial growth factor, providing the stimulus for neovascular disease.
年龄相关性黄斑变性(AMD)是一种多因素疾病,遗传和环境因素均会增加患病风险。AMD潜在的组织病理学变化尚未完全明确,尤其是脉络膜毛细血管(CC)功能障碍与该疾病表型变异性之间的关系。
研究临床确诊为AMD的眼睛中CC的组织病理学变化。
设计、地点和参与者:该研究于2011年设计。2012年至2016年收集尸检组织,并从1988年以来参与AMD研究的参与者中获取组织病理学图像。按照标准方案收集参与者的临床记录和图像。对无AMD的眼睛(n = 4)以及患有早期(n = 9)、中期(n = 5)和晚期AMD(地图样萎缩,n = 5;新生血管疾病,n = 13)的眼睛进行评估。使用欧洲荆豆凝集素标记脉络膜血管,并通过共聚焦显微镜进行检查。
应用标准化分类系统确定AMD分期。复查眼部记录和图像并进行组织病理学分析。分析每个AMD分期脉络膜血管的活力。
所有参与者均为白人。14名男性,16名女性。AMD患者的平均年龄为90.5岁,对照参与者的平均年龄为88.5岁。在所有早期AMD病例中均观察到黄斑下CC缺失且无视网膜色素上皮(RPE)丢失。与对照参与者相比,每个AMD分期的血管面积损失更高:早期AMD为20.5%(95%CI,11.2% - 40.2%;P <.001),中期AMD为12.5%(95%CI,2.9% - 21.4%;P = 0.01),地图样萎缩为39.0%(95%CI,32.1% - 45.4%;P <.001),新生血管疾病且RPE保持完整为38.2%(95%CI,27.7% - 47.9%;P <.001)。在22.2%的早期AMD眼睛和40%的中期AMD眼睛中,高细胞性、明显的新生血管芽与CC缺失区域相邻。
在地图样萎缩中,视网膜色素上皮萎缩先于CC缺失,但在9只早期AMD眼睛中有2只在无RPE萎缩的情况下发生了CC缺失。鉴于本研究的横断面性质以及评估的眼睛数量较少,无法确定关于这种进展的确切结论。我们推测新生血管芽可能是新生血管疾病的先兆。血液供应减少导致的缺氧RPE可能上调血管内皮生长因子的产生,为新生血管疾病提供刺激。